HomeTARA • NASDAQ
add
Protara Therapeutics Inc
Previous close
$4.11
Day range
$4.10 - $4.50
Year range
$1.60 - $10.48
Market cap
158.84M USD
Avg Volume
315.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.31M | 29.63% |
Net income | -12.77M | -24.93% |
Net profit margin | — | — |
Earnings per share | -0.43 | 52.22% |
EBITDA | -14.23M | -30.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 170.29M | 159.67% |
Total assets | 181.45M | 129.82% |
Total liabilities | 14.32M | 34.68% |
Total equity | 167.13M | — |
Shares outstanding | 36.77M | — |
Price to book | 0.86 | — |
Return on assets | -25.97% | — |
Return on capital | -27.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.77M | -24.93% |
Cash from operations | -9.31M | -6.99% |
Cash from investing | 22.50M | 54.98% |
Cash from financing | 97.85M | — |
Net change in cash | 111.04M | 1,808.58% |
Free cash flow | -3.96M | 25.62% |
About
Founded
2006
Website
Employees
31
